| (Values in U.S. Thousands) | Dec, 2022 | Dec, 2021 | Dec, 2020 | Dec, 2025 | Dec, 2025 |
| Sales | 226,580 | 0 | 0 | 0 | 0 |
| Sales Growth | unch | unch | unch | unch | unch |
| Net Income | 98,290 | -45,900 | -13,370 | 0 | 0 |
| Net Income Growth | +314.14% | -243.31% | unch | unch | unch |
Point Biopharma Global Inc (PNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
POINT Biopharma Global Inc. is a radiopharmaceutical company. It builds a platform for the clinical development and commercialization of radioligands which fight cancer. POINT Biopharma Global Inc., formerly known as Research Alliance Corp., is based in INDIANAPOLIS.
Fiscal Year End Date: 12/31